Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kovax Flu PF
- Development stage
- Unknown
- Lead developer
- Koreavaccine
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Kovax Flu PF is an inactivated, split-virion influenza vaccine developed by Koreavaccine for the prevention of influenza caused by influenza A and B viruses. It is approved for use in a broad population, including infants from 6 months of age, children, adolescents, and adults. The vaccine is presented in a pre-filled syringe (PF) for intramuscular administration. As a split-virion vaccine, it contains viral components that have been chemically disrupted, primarily focusing on the hemagglutinin (HA) surface proteins of the influenza strains recommended by the WHO for the specific flu season. By introducing these antigens, the vaccine stimulates the host's immune system to produce neutralizing antibodies, providing active immunity against the circulating H1N1, H3N2, and B-lineage strains.
- Brand names
- Kovax Flu PFKovax Flu PF Inj.
- Other names
- Kovax FluKoreavaccine influenza vaccine
02
Targets
HA (Hemagglutinin)Neuraminidase
Beyond the preview
Go deeper on Kovax Flu PF.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kovax Flu PF.